Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fungal cell membrane ergosterol synthesis enzymes comprise a group of enzymes essential for the biosynthesis of ergosterol, a sterol unique to fungi and some protists that is crucial for maintaining cell membrane integrity and function. These enzymes are key targets for antifungal drugs because mammals utilize cholesterol instead of ergosterol. The pathway involves multiple enzymatic steps, starting from acetyl-CoA and culminating in the production of ergosterol. Key enzymes include squalene epoxidase (Erg1) and lanosterol 14α-demethylase (CYP51/Erg11). Inhibition of these enzymes leads to impaired fungal growth or death, making them essential targets for antifungal therapies. Resistance can develop via mutations or overexpression in key ERG genes.
Inhibition of ergosterol synthesis, leading to membrane disruption or accumulation of toxic sterol intermediates
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal Cell Membrane Ergosterol Synthesis Enzymes.